⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MLTX News
MoonLake Immunotherapeutics Class A Ordinary Shares
Securities Lawsuit Alert: MoonLake Immunotherapeutics (MLTX) - Contact Levi & Korsinsky Before December 15, 2025
accessnewswire.com
MLTX
MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman
accessnewswire.com
MLTX
Pomerantz LLP Alerts Shareholders to Investor Suit Filed Against MoonLake Immunotherapeutics – MLTX
accessnewswire.com
MLTX
Investor Alert: Deadline Approaching to Join MoonLake Immunotherapeutics (MLTX) Class Action - Contact Levi & Korsinsky
accessnewswire.com
MLTX
MoonLake Immunotherapeutics (MLTX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
prnewswire.com
MLTX
MLTX COURT NEWS: MoonLake Immunotherapeutics Investor Deadline December 15 - Investors Notified to Contact BFA Law to Potentially Recover Losses
accessnewswire.com
MLTX
Class Action Alert: Levi & Korsinsky Reminds MoonLake (MLTX) Investors of December 15, 2025 Deadline
accessnewswire.com
MLTX
Class Action Filed Against MoonLake Immunotherapeutics (MLTX) Over Securities Violations - Contact Levi & Korsinsky Today
accessnewswire.com
MLTX
Levi & Korsinsky Notifies MoonLake Immunotherapeutics (MLTX) Shareholders of Class Action Lawsuit and December 15, 2025 Deadline
accessnewswire.com
MLTX
Levi & Korsinsky Notifies MoonLake Immunotherapeutics Investors of a Class Action Lawsuit and Upcoming Deadline - MLTX
prnewswire.com
MLTX